RT Journal Article
SR Electronic
T1 Serial electrophysiologic testing of drug therapy in supraventricular tachycardia related to accessory pathways
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 622
OP 626
VO 57
IS 7
A1 Hassan M.K. Nagi
A1 Sergio L. Pinski
A1 Sherif Mokhtar
A1 Yehia Saad
A1 James D. Maloney
YR 1990
UL http://www.ccjm.org/content/57/7/622.abstract
AB Data are limited on the use of serial electrophysiologic testing of drug therapy in patients with supraventricular tachycardia associated with accessory pathways, including the Wolff-Parkinson-White syndrome. Twenty-four highly symptomatic patients (aged 36 ± 11 years) with SVT related to accessory pathways underwent electrophysiologic studies to select an effective chronic oral treatment. Conventional (verapamil, propranolol, quinidine, disopyramide) and investigational (amiodarone, aprindine, propafenone) drugs were used alone and in combination if necessary. It was determined that serial electrophysiologic studies could identify potentially effective treatments in 6 6 % of patients with reentrant S V T involving accessory pathways, and the findings were highly predictive of long-term clinical outcome.